SCHEMBL30926697

SCHEMBL30926697

COc1ccc(S(=O)(=O)Nc2ccccc2NC(=O)c2ccc(Cl)cc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 1/20 0.64
HDAC3 O15379 5/20 0.63
HDAC1 Q13547 4/20 0.63
NCOR2 Q9Y618 4/20 0.63
HDAC2 Q92769 4/20 0.63
EGFR P00533 1/20 0.56
FGFR1 P11362 1/20 0.56
KDR P35968 1/20 0.56
KEAP1 Q14145 2/20 0.55
MEN1 O00255 3/20 0.54
LMNA P02545 3/20 0.54
KMT2A Q03164 3/20 0.54
ALDH1A1 P00352 3/20 0.54
MAPT P10636 2/20 0.54
HTT P42858 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
HDAC4 P56524 1/20 0.54
HDAC7 Q8WUI4 1/20 0.54
HDAC10 Q969S8 1/20 0.54
HDAC11 Q96DB2 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27180977 1.00 F10 (0.64) F10HDAC3HDAC1NCOR2HDAC2
SCHEMBL8625192 0.90 F10 (0.67) F10HDAC3HDAC1NCOR2HDAC2
SCHEMBL8625679 0.89 TUBB4A (0.68) F10HDAC3HDAC1NCOR2HDAC2
SCHEMBL8627623 0.88 F10 (0.64) F10HDAC3HDAC1NCOR2HDAC2
SCHEMBL27180645 0.86 KMT2A (0.71) KDRMEN1LMNAKMT2AALDH1A1
SCHEMBL8625175 0.86 FLT1 (0.64) KDRMEN1LMNAKMT2AALDH1A1
SCHEMBL30926938 0.86 KMT2A (0.71) KDRMEN1LMNAKMT2AALDH1A1
SCHEMBL8626468 0.86 SMN1; SMN2 (0.69) F10HDAC3HDAC1NCOR2HDAC2
SCHEMBL30926935 0.84 KMT2A (0.61) KDRMEN1LMNAKMT2AALDH1A1
SCHEMBL27180994 0.84 KMT2A (0.61) KDRMEN1LMNAKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS APEH, ARSA, DNPEP F10 4186/4885HDAC3 3268/4885HDAC1 2147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.